Sponsors (21)
The bill modernizes and authorizes federal breast and cervical cancer screening efforts—adding quality, navigation, and evidence‑based approaches and signaling stable funding—while creating legal, coverage-predictability, and fiscal risks that could limit consistent access and state implementation, especially for low-income women.
Women (including low-income and Medicaid beneficiaries) will have guaranteed appropriate follow-up after screening, improving timely diagnosis and care.
Women—especially underserved groups—will gain expanded prevention, navigation, and evidence-based strategies in the program, which should raise screening uptake and early detection.
State governments and women will benefit from requirements that grant recipients ensure the quality of screening and diagnostic services, likely raising clinical and program standards.
Women (particularly low-income individuals) may face reduced predictability and greater state-to-state variability in which screening tests and follow-up services are covered because the bill shifts to evidence‑based recommendations and removes some specific statutory service mandates.
Fiscal and implementation uncertainty: the authorization does not guarantee appropriations and expanding duties or reporting could increase costs, risking constrained services or higher taxpayer/federal program costs.
Replacing detailed statutory language without clear new text could create legal and programmatic uncertainty for stakeholders about program scope, rules, and benefits.
Based on analysis of 2 sections of legislative text.
Reauthorizes and modernizes the National Breast and Cervical Cancer Early Detection Program, revises purposes and advisory provisions, requires a GAO report, and funds $235.5M/year for FY2026–2030.
Reauthorizes and revises the federal National Breast and Cervical Cancer Early Detection Program and updates the Young Women’s Breast Health Education and Awareness (EARLY) Act provisions. The bill modernizes program purpose language to emphasize prevention, access, navigation, evidence-based strategies and reducing disparities, replaces certain advisory/committee language, requires a Comptroller General report on program eligibility and trends, and authorizes $235.5 million per year for FY2026–2030.
Official title: To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Introduced July 17, 2025 by Debbie Wasserman Schultz · Last progress July 27, 2026